Login

Financial Snapshot

Revenue
TTM
$182.0K
Gross Margin
TTM
83.68%
Net Income
TTM
-$613.6K
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
2.81%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
-$17.26M
Cash
2026 Q1
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$327.8K

Stock Price

Loading...
Market Cap: $709.97 Thousand

About NUTRA PHARMA CORP

Nutra Pharma Corp. operates as a bio pharmaceutical company. The company is headquartered in Plantation, Florida and currently employs 6 full-time employees. The company went IPO on 2001-10-09. The firm's drug candidates include RPI-MN and RPI-78M. Additionally, the Company markets drug products for sale for the treatment of pain under the brand Nyloxin and Pet Pain-Away. Its pain relief categories include arthritis pain, chronic back pain, headaches and migraines, and knee and joint pain. Its over the counter (OTC) homeopathic products include Nyloxin Topical Gel, Extra Strength Nyloxin Topical Gel, Nyloxin Oral Spray, Extra Strength Nyloxin Oral Spray, Nyloxin Topical Gel Roll On, Nyloxin Professional Size Pump Topical Gel and Pet Pain Away. The firm's holds approximately 21 patents in their portfolio.

Industry: Medicinal Chemicals & Botanical Products Peers: Fresh Tracks Therapeutics, Inc. Panbela Therapeutics, Inc. CONTRAFECT Corp Creative Medical Technology Holdings Inc Kiromic Biopharma, Inc. MANHATTAN SCIENTIFICS INC Revelation Biosciences Inc Scopus BioPharma Inc.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support